BioSpace News Archive

Innotech Nutrition, a Canadian based manufacturer of natural health products is very excited to release the results of an in-vitro study conducted by Dr. Craig Meyers MS, PhD and his scientific team from Penn State College of Medicine at Pennsylvania State University

LimaCorporate S.p.A., leading global orthopedics manufacturer, and Hospital for Special Surgery, top-ranked in orthopedics for 11 consecutive years in the U.S., by U.S. News & World Report., announce the opening of the first provider-based design and 3D printing facility for custom complex joint replacement solutions.

Mission Therapeutics, a drug discovery and development company focused on selectively inhibiting deubiquitylating enzymes, announces the appointment of Jonathan Hepple to the Company’s Board as a Non-Executive Director.

United Therapeutics Corporation announced that Dr. Gil Golden, Executive Vice President and Chief Medical Officer of United Therapeutics, will provide an overview and update on the company’s business during a fireside chat session at the 10th Annual J.P. Morgan Napa Valley Forum.

- In just eight seconds, harmful bacteria, viruses, and fungus clinging to the soles of your shoes – including those associated with COVID-19, MRSA, and other public health scourges – can be stopped dead in their tracks. And one of Corning’s most venerable glass innovations helps make it happen.

LetsGetChecked, a leading direct-to-consumer health testing and insights company, announces today the authorization by the Food and Drug Administration (FDA) of its Coronavirus (COVID-19) home collection test now available without a prescription.

BiomX Inc., a clinical-stage microbiome company advancing natural and engineered phage therapies that target specific pathogenic bacteria, announced that the Company will host a conference call and live audio webcast on Wednesday, March 31, 2021, at 8:00 a.m. EDT, to report fourth quarter and full year 2020 financial results.

Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, reported financial results for the fourth quarter and full year ended December 31, 2020 and provided key business updates.

ChromaDex Corp. announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Kevin Farr, will be presenting virtually at the Lytham Partners Spring 2021 Investor Conference.

BrainStorm Cell Therapeutics Inc . (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today topline data from the Company’s Phase 2 trial evaluating three repeated administrations of NurOwn® (MSC-NTF cells), each given 2 months apart, as a treatment for progressive multiple sclerosis (MS).